top of page
Government agrees to full consultation of the Medical Innovation Bill
The government agreed to full consultation of the Medical Innovation Bill spearheaded by Lord Saatchi. Jeremy Hunt, the Secretary of...
NCRI and Cancer52 publish report on research spend
A new report from the National Cancer Research Institute (NCRI) and Cancer52 was published in November 2013, showing for the first time...
Cancer52 Third Annual Briefing 2013
Cancer52's Third Annual Briefing was held in October 2013 at the House of Lords. To read a summary debrief of the event please click here.
Briefing paper on Value Based Pricing and Cancer Drugs Fund
On 20th September 2013, Cancer52 published Briefing Papers on Value Based Pricing (VBP) and the Cancer Drugs Fund (CDF); alongside an...


Our Chair, Allyson Kaye, has been awarded an MBE in the New Years Honours List 2014 for services to
Allyson founded Ovarian Cancer Action in 2004, as a campaigning voice for women with ovarian cancer - lobbying for greater understanding...
Media coverage of rare and less common cancers
Rare and less common cancers are going up the media agenda - in June 2013 there was a massive piece in the Telegraph on neuro endocrine...
BBC Scotland programme "Life, Death and Enormous Amounts of Money"
Cancer52 supported the CML Support Group's call for an apology from BBC Scotland for footage within its programme "Life, Death and...
Position statement on Value Based Pricing
On 13th November 2012, Cancer52 published its Position Statement on Value Based Pricing.


QiC Excellence in Oncology Awards
Simon Davies, Chair of Cancer52, presented Professor Sir Mike Richards CBE with his Lifetime Achievement Award at the QiC Oncology Awards...
Cancer52 Annual Review 2012
Cancer 52's Annual Review 2012 summarises the growth of the organisation and highlights of its activities. Please click here to download...
bottom of page